Common Health partners with biopharmaceutical innovators to bring essential medicines to the patients and health systems who need them most — across Asia Pacific's frontier markets, from regulatory registration to the last mile of patient care.
Modern medicine saves lives — but for patients across Asia Pacific's frontier markets, that benefit often stays out of reach. Fragmented regulatory systems, thin health infrastructure, and markets too small to prioritize on their own mean that essential, life-saving therapies frequently never reach the people who need them.
This isn't a shortage of good medicine. It's a gap in how that medicine gets to patients.
Common Health exists to close that gap. We partner with biopharmaceutical innovators to bring their medicines to patients across Asia Pacific's frontier markets — safely, sustainably, and affordably — handling the full path from regulatory registration to the patients who ultimately need care.
Reaching people is only the first step. We work beyond supply — on diagnosis, healthcare provider education, and patient support — because access to a medicine and access to care aren't the same thing.
Registration, marketing authorization, and ongoing pharmacovigilance that bring safe, quality-assured medicines to new markets — and keep them safely monitored once patients are using them.
Formulary and essential-medicines-list inclusion, tender participation, and payer engagement — the work that determines whether a medicine is reachable through the public health systems patients actually rely on.
Healthcare provider education and engagement that builds clinical confidence and appropriate use — grounded in real medical affairs relationships, not promotion for its own sake.
Import, warehousing, and last-mile delivery — including cold-chain handling — built for health systems where the physical supply chain is often the hardest barrier to care.
Programs that keep patients on therapy once they're prescribed it — adherence support, affordability mechanisms, and patient-facing services suited to frontier-market realities.
Ongoing, on-the-ground visibility into patient needs, treatment gaps, and health outcomes — so partners understand not just where medicine is going, but who it's actually reaching.
Whether you're evaluating a single frontier market or the full region, we'd welcome the conversation.
Contact Us